What genetic counseling should be offered to a girl with non‑classic congenital adrenal hyperplasia (CAH) regarding genetic testing, inheritance risks, and management?

Genetic Counseling for Non-Classic CAH (Possible Heterozygote)

A girl with non-classic CAH who may be a heterozygote should receive formal genetic counseling that includes CYP21A2 genotyping for herself and potentially her partner when planning reproduction, with clear explanation that her offspring risk depends on her partner's carrier status—approximately 1 in 240 risk for classic CAH if her partner is from the general population, but substantially higher (2.5-8%) if her partner is also a carrier. 1

Understanding the Inheritance Pattern

Non-classic CAH follows autosomal recessive inheritance through mutations in the CYP21A2 gene 1. The key genetic counseling points are:

For the Patient Herself

• If she has non-classic CAH, she carries two mutant CYP21A2 alleles (often compound heterozygote with one mild and one severe mutation)
• About two-thirds of non-classic CAH patients are compound heterozygotes, carrying one allele causing classic CAH and one causing non-classic CAH 1
• The milder mutation determines her phenotype, which is why she has non-classic rather than classic disease 1

Reproductive Risk Assessment

The critical factor is partner carrier status:

• General population carrier frequency: 1 in 50-71 (approximately 1.5-2%) 1
• Ashkenazi Jewish population: 15% carrier rate 2
• Other Caucasians: 9.5% carrier rate 2

Offspring risks if she has non-classic CAH:

• Risk of child with classic CAH: 1 in 240 (theoretical calculation) 1
• Actual observed risk: 2.5% based on retrospective data of 162 children born to non-classic CAH women 1
• Risk increases to 8% for any form of CAH if partner carries mutations (French data) 1

Recommended Genetic Testing Strategy

Genotyping should be performed in certified laboratories with quality controls capable of CYP21A2 gene sequencing 1, 3. The Endocrine Society guidelines specifically state that genotyping is reserved for equivocal cases and genetic counseling 1.

Testing Approach:

1. Confirm her diagnosis with CYP21A2 genotyping if not already done
2. Partner testing should be offered before conception planning
3. Testing is complex due to gene duplications, deletions, and rearrangements on chromosome 6p21.3 1
4. More than 100 CYP21A2 mutations exist, but 10 mutations account for ~95% of affected alleles 4

Common Mutations to Know:

• Val281Leu (exon 7): Accounts for ~70% of non-classic CAH alleles, preserves 20-50% enzyme function 1
• Ile172Asn (exon 4): Associated with simple virilizing classic CAH, preserves 1-2% function 1
• Large deletions and intron 2 splice mutations: Ablate enzyme activity, cause salt-wasting CAH 1

Timing of Genetic Counseling

The Endocrine Society recommends genetic counseling at two critical timepoints 1:

1. At birth of a CAH child (for parents)
2. At adolescence during transition to adult care (for the patient herself)

For this girl, counseling should occur before reproductive age and be reinforced when she begins considering pregnancy.

Preconception and Pregnancy Planning Options

If Avoiding CAH in Offspring:

• Partner genotyping is essential first step 1
• If partner is a carrier, consider:
  • In vitro fertilization with preimplantation genetic testing for monogenic disorders 5
  • Prenatal diagnosis via chorionic villus sampling or amniocentesis 5
  • Maternal cell-free DNA for fetal sex determination 5

Important Caveat:

Prenatal dexamethasone treatment to prevent virilization remains experimental and is NOT recommended outside research protocols 1. The Endocrine Society explicitly states prenatal treatment should "continue to be regarded as experimental" 1.

Clinical Management Considerations

For Her Current Health:

• Non-classic CAH generally does not cause Addisonian crises 1
• Treatment is only for symptomatic patients (hirsutism, menstrual irregularities, fertility issues) 1, 6
• Glucocorticoids should be used judiciously; antiandrogens and oral contraceptives are often preferable for symptom control 6, 7

Fertility Implications:

• Women with non-classic CAH have reduced fecundity (0.25 live births per woman vs 1.8 in general population for classic CAH) 1
• Non-classic CAH may cause infertility through androgen excess, dysovulation, and progesterone-mediated implantation issues 6
• Fertility specialist consultation is suggested if conception difficulties arise 1

Key Counseling Messages

Emphasize these points:

1. Her children's risk depends entirely on her partner's genetics—testing him is crucial for accurate risk assessment

2. Ethnic background matters significantly—Ashkenazi Jewish ancestry increases carrier rates from 1.5% to 15% 2

3. Most carriers are asymptomatic—her partner likely wouldn't know he's a carrier without testing

4. Even if partner is a carrier, there are reproductive options including IVF with genetic testing 5

5. Her own health management should focus on symptom control with minimal glucocorticoid exposure 6

6. Quality of life considerations should guide treatment decisions, with mental health support as needed 1

Common Pitfalls to Avoid

• Don't assume low risk without partner testing—actual observed risks (2.5-8%) are higher than theoretical calculations 1
• Don't use routine glucocorticoids unless she's symptomatic or seeking fertility 1, 6
• Don't recommend prenatal dexamethasone—it remains experimental 1
• Ensure laboratory quality—CYP21A2 genotyping is technically challenging and requires specialized expertise 1, 3